Skip to main content
. Author manuscript; available in PMC: 2013 Jul 18.
Published in final edited form as: Aliment Pharmacol Ther. 2011 Nov 30;35(2):255–265. doi: 10.1111/j.1365-2036.2011.04926.x

Table 3.

Fibrosis markers*

Markers, ng/mL Baseline (n = 12) 4 months (n = 12) Mean (S.E.) 9 months (n = 13)
HA 154.7 (±40.3) 134.1 (±37.9) 147.9 (±35.1)
PIIINP 13.7 (±1.9) 12.6 (±1.8) 15.4 (±2.2)
TIMP-1 811.5 (±94.2) 703.2 (±68.3) 747.5 (±84.9)
ELF Score (normal range: 0–6.6) 10.1 (±.48) 10.1 (±.32) 10.2 (±.40)

S.E., standard error of the mean; HA, hyaluronic acid; PIIINP, amino-terminal propeptide-of-type-III-collagen; TIMP-1, tissue-inhibitor of matrix-metaloproteinas-1; ELF, enhanced liver fibrosis.

*

These data are from the Beth Israel Deaconess Medical Center subjects only.

HHS Vulnerability Disclosure